Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ELCC 2019 | A STELLAR study: TTFields for malignant pleural mesothelioma

In this interview, Ori Farber, MD, of Novocure, Haifa, Israel, discusses the promising results of the STELLAR study (NCT02397928) utilizing tumor treating fields (TTF) for the treatment of malignant pleural mesothelioma. This video was recorded at the European Lung Cancer Congress (ELCC) 2019, held in Geneva, Switzerland.